"LM_ID","COMMON_NAME","SYSTEMATIC_NAME","FORMULA","MASS","CATEGORY","MAIN_CLASS","SUB_CLASS","CLASS_LEVEL4","SYNONYMS","INCHI_KEY","INCHI","SMILES","KEGG_ID","HMDBID","CHEBI_ID","ABBREVIATION","PUBCHEM_COMPOUND_ID","LIPIDBANK_ID","SWISSLIPIDS_ID","CAYMAN_ID","ALT_CATEGORIES","ALT_MAIN_CLASSES","ALT_SUB_CLASSES","ALT_CLASS_LEVEL4S","TAXONOMY","CITATION"
"LMSP0505AI03","type III H antigen(d18:1/20:0)","Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)","C90H161N3O41","1940.060564","Sphingolipids [SP]","Neutral glycosphingolipids [SP05]","Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]","-","-","QKXYBXGGIYGSGU-HBXLANMWSA-N","InChI=1S/C90H161N3O41/c1-7-9-11-13-15-17-19-21-22-23-24-26-28-30-32-34-36-38-58(103)93-50(51(102)37-35-33-31-29-27-25-20-18-16-14-12-10-8-2)45-119-85-74(117)71(114)77(57(44-99)127-85)128-88-75(118)79(65(108)54(41-96)123-88)131-83-59(91-48(5)100)67(110)76(56(43-98)126-83)129-90-82(134-87-73(116)69(112)62(105)47(4)121-87)80(66(109)55(42-97)125-90)132-84-60(92-49(6)101)78(64(107)53(40-95)122-84)130-89-81(70(113)63(106)52(39-94)124-89)133-86-72(115)68(111)61(104)46(3)120-86/h35,37,46-47,50-57,59-90,94-99,102,104-118H,7-34,36,38-45H2,1-6H3,(H,91,100)(H,92,101)(H,93,103)/b37-35+/t46-,47-,50+,51-,52-,53-,54-,55-,56-,57-,59-,60-,61-,62-,63+,64+,65+,66+,67-,68-,69-,70+,71-,72+,73+,74-,75-,76-,77-,78-,79+,80+,81-,82-,83+,84-,85-,86-,87-,88+,89+,90+/m1/s1","[C@](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@H]5O[C@H](CO)[C@H](O)[C@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O[C@H]6O[C@H](C)[C@@H](O)[C@@H](O)[C@@H]6O)[C@H]5NC(=O)C)[C@H]4O[C@H]4O[C@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H](O)[C@H]3NC(=O)C)[C@H]2O)[C@H](O)[C@H]1O)([H])(NC(CCCCCCCCCCCCCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC","-","-","-","Hex(4)-HexNAc(2)-Fuc(2)-Cer 38:1;O2","44261038","-","-","-","-","-","-","-","-","-"